165 related articles for article (PubMed ID: 1320364)
1. In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116.
Imada T; Miyazaki S; Nishida M; Yamaguchi K; Goto S
Antimicrob Agents Chemother; 1992 Mar; 36(3):573-9. PubMed ID: 1320364
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of OPC-17116 against important pathogens that cause respiratory tract infections.
Wakebe H; Imada T; Yoneda H; Mukai F; Ohguro K; Ohmori K; Tamaoka H; Yabuuchi Y
Antimicrob Agents Chemother; 1994 Oct; 38(10):2340-5. PubMed ID: 7840567
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone.
Hosaka M; Yasue T; Fukuda H; Tomizawa H; Aoyama H; Hirai K
Antimicrob Agents Chemother; 1992 Oct; 36(10):2108-17. PubMed ID: 1332587
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria.
Wakebe H; Mitsuhashi S
Antimicrob Agents Chemother; 1992 Oct; 36(10):2185-91. PubMed ID: 1332589
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative.
Fukuoka Y; Ikeda Y; Yamashiro Y; Takahata M; Todo Y; Narita H
Antimicrob Agents Chemother; 1993 Mar; 37(3):384-92. PubMed ID: 8460909
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone.
Nakamura S; Minami A; Nakata K; Kurobe N; Kouno K; Sakaguchi Y; Kashimoto S; Yoshida H; Kojima T; Ohue T
Antimicrob Agents Chemother; 1989 Aug; 33(8):1167-73. PubMed ID: 2802544
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo activities of a new quinolone, WIN 57273, possessing potent activity against gram-positive bacteria.
Sedlock DM; Dobson RA; Deuel DM; Lesher GY; Rake JB
Antimicrob Agents Chemother; 1990 Apr; 34(4):568-75. PubMed ID: 2344163
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antibacterial activities of DK-507k, a novel fluoroquinolone.
Otani T; Tanaka M; Ito E; Kurosaka Y; Murakami Y; Onodera K; Akasaka T; Sato K
Antimicrob Agents Chemother; 2003 Dec; 47(12):3750-9. PubMed ID: 14638477
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones.
Sader HS; Erwin ME; Jones RN
Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):372-81. PubMed ID: 1327789
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of OPC-17116.
Neu HC; Fang W; Gu JW; Chin NX
Antimicrob Agents Chemother; 1992 Jun; 36(6):1310-5. PubMed ID: 1329620
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antibacterial activities of CS-940, a new 6-fluoro-8-difluoromethoxy quinolone.
Masuda N; Takahashi Y; Otsuki M; Ibuki E; Miyoshi H; Nishino T
Antimicrob Agents Chemother; 1996 May; 40(5):1201-7. PubMed ID: 8723467
[TBL] [Abstract][Full Text] [Related]
12. Dissociated resistance among fluoroquinolones.
Thomson KS; Sanders CC
Antimicrob Agents Chemother; 1994 Sep; 38(9):2095-100. PubMed ID: 7811025
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evaluations of A-80556, a new fluoroquinolone.
Clement JJ; Tanaka SK; Alder J; Vojtko C; Beyer J; Hensey D; Ramer N; McDaniel D; Chu DT
Antimicrob Agents Chemother; 1994 May; 38(5):1071-8. PubMed ID: 8067740
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin.
Barry AL; Fuchs PC
Antimicrob Agents Chemother; 1991 May; 35(5):955-60. PubMed ID: 1906696
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antibacterial activities of Q-35, a novel fluoroquinolone.
Iwasaki H; Miyazaki S; Tsuji A; Yamaguchi K; Goto S
Chemotherapy; 1995; 41(2):100-12. PubMed ID: 7758353
[TBL] [Abstract][Full Text] [Related]
17. In-vitro and in-vivo antibacterial activity of CFC-222, a new fluoroquinolone.
Kim JH; Choi KH; Kim JW; Lee JH; Choi EC; Kim BK
J Antimicrob Chemother; 1998 Feb; 41(2):223-9. PubMed ID: 9533464
[TBL] [Abstract][Full Text] [Related]
18. In-vitro and in-vivo activities of DW-116, a new fluoroquinolone.
Choi KH; Hong JS; Kim SK; Lee DK; Yoon SJ; Choi EC
J Antimicrob Chemother; 1997 Apr; 39(4):509-14. PubMed ID: 9145824
[TBL] [Abstract][Full Text] [Related]
19. In vivo evaluation of NM441, a new thiazeto-quinoline derivative.
Ozaki M; Matsuda M; Tomii Y; Kimura K; Segawa J; Kitano M; Kise M; Shibata K; Otsuki M; Nishino T
Antimicrob Agents Chemother; 1991 Dec; 35(12):2496-9. PubMed ID: 1667252
[TBL] [Abstract][Full Text] [Related]
20. Activity of temafloxacin against respiratory pathogens.
Swanson RN; Hardy DJ; Chu DT; Shipkowitz NL; Clement JJ
Antimicrob Agents Chemother; 1991 Mar; 35(3):423-9. PubMed ID: 2039192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
